Compagnie Lombard Odier SCmA’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,900
| Closed | -$296K | – | 715 |
|
|
2020
Q4 | $296K | Buy |
1,900
+1,872
| +6,686% | +$292K | 0.01% | 286 |
|
|
2020
Q3 | $3K | Buy |
+28
| New | +$3K | ﹤0.01% | 498 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 621 |
|
|
2019
Q1 | – | Sell |
-1,400
| Closed | -$136K | – | 606 |
|
|
2018
Q4 | $136K | Sell |
1,400
-3,230
| -70% | -$314K | 0.01% | 301 |
|
|
2018
Q3 | $644K | Hold |
4,630
| – | – | 0.02% | 178 |
|
|
2018
Q2 | $575K | Hold |
4,630
| – | – | 0.02% | 195 |
|
|
2018
Q1 | $516K | Sell |
4,630
-2,230
| -33% | -$249K | 0.02% | 217 |
|
|
2017
Q4 | $820K | Buy |
6,860
+3,430
| +100% | +$410K | 0.01% | 246 |
|
|
2017
Q3 | $481K | Hold |
3,430
| – | – | 0.02% | 270 |
|
|
2017
Q2 | $417K | Hold |
3,430
| – | – | 0.01% | 291 |
|
|
2017
Q1 | $416K | Sell |
3,430
-1,100
| -24% | -$133K | 0.01% | 300 |
|
|
2016
Q4 | $555K | Sell |
4,530
-1,400
| -24% | -$172K | 0.02% | 319 |
|
|
2016
Q3 | $727K | Hold |
5,930
| – | – | 0.02% | 309 |
|
|
2016
Q2 | $693K | Hold |
5,930
| – | – | 0.02% | 304 |
|
|
2016
Q1 | $825K | Sell |
5,930
-1,360
| -19% | -$189K | 0.03% | 276 |
|
|
2015
Q4 | $1.39M | Sell |
7,290
-140
| -2% | -$26.7K | 0.04% | 197 |
|
|
2015
Q3 | $1.16M | Buy |
7,430
+3,726
| +101% | +$583K | 0.05% | 185 |
|
|
2015
Q2 | $669K | Sell |
3,704
-756
| -17% | -$137K | 0.02% | 262 |
|
|
2015
Q1 | $773K | Buy |
4,460
+3,654
| +453% | +$633K | 0.03% | 256 |
|
|
2014
Q4 | $149K | Sell |
806
-444
| -36% | -$82.1K | 0.01% | 466 |
|
|
2014
Q3 | $208K | Buy |
1,250
+189
| +18% | +$31.5K | 0.01% | 496 |
|
|
2014
Q2 | $166K | Hold |
1,061
| – | – | 0.01% | 561 |
|
|
2014
Q1 | $161K | Sell |
1,061
-738
| -41% | -$112K | 0.01% | 569 |
|
|
2013
Q4 | $239K | Buy |
+1,799
| New | +$239K | 0.01% | 486 |
|